Dexamethasone implant shows comparable outcomes in vitrectomized, non-vitrectomized eyes

FORT LAUDERDALE, Fla. — A study found that the efficacy and safety of the Ozurdex implant for diabetic macular edema are comparable in vitrectomized vs. non-vitrectomized eyes.
“Efficacy was not influenced by full vitrectomy for diabetic retinopathy complications, and the safety profile was well balanced between groups,” Matias Iglicki, MD, said at the Retina World Congress.
The VITDEX study was conducted by the International Retina Group, a collaborative network of specialists from 14 countries around the world. The aim was to compare the visual and anatomical outcomes in

FORT LAUDERDALE, Fla. — A study found that the efficacy and safety of the Ozurdex implant for diabetic macular edema are comparable in vitrectomized vs. non-vitrectomized eyes.
“Efficacy was not influenced by full vitrectomy for diabetic retinopathy complications, and the safety profile was well balanced between groups,” Matias Iglicki, MD, said at the Retina World Congress.
The VITDEX study was conducted by the International Retina Group, a collaborative network of specialists from 14 countries around the world. The aim was to compare the visual and anatomical outcomes in